Carbapenem resistance in Escherichia coli associated with plasmid- determined CMY-4 β-lactamase production and loss of an outer membrane protein

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 5, 1999, Pages 1206-1210

  Stapleton, Paul D ^a,b   Shannon, Kevin P ^a   French, Gary L ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ARGININE; AZTREONAM; BETA LACTAMASE; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CLAVULANIC ACID; IMIPENEM; LATAMOXEF; MEROPENEM; OUTER MEMBRANE PROTEIN; PIPERACILLIN; TRYPTOPHAN;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CELL MEMBRANE PERMEABILITY; ENZYME ACTIVITY; ENZYME SYNTHESIS; ESCHERICHIA COLI; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION;

EID: 0032926983     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.5.1206     Document Type: Article

References (29)

1. Ausubel, F. M., R. Brent, R. F. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1987. Current protocols in molecular biology. Greene Publishing Associates and Wiley-Interscience, New York, N.Y.
2. Bauernfeind, A., I. Stemplinger, R. Jungwirth, and H. Glamarellou. 1996. Characterization of the plasmidic β-lactamase CMY-2, which is responsible for cephamycin resistance. Antimicrob. Agents Chemother. 40:221-224.
3. Bishop, R. E., S. S. Penfold, L. S. Frost, J.-V. Höltje, and J. H. Weiner. 1995. Stationary phase expression of a novel Escherichia coli outer membrane lipoprotein and its relationship with mammalian apolipoprotein D. Implications for the origins of lipocalins. J. Biol. Chem. 270:23097-23103.
4. Bradford, P. A., C. Urban, N. Mariano, S. J. Projan, J. J. Rahal, and K. Bush. 1997. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein. Antimicrob. Agents Chemother. 41:563-569.
5. Bret, L., C. Chanal-Claris, D. Sirot, E. B. Chaibi, R. Labia, and J. Sirot. 1998. Chromosomally encoded AmpC-type β-lactamase in a clinical isolate of Proteus mirabilis. Antimicrob. Agents Chemother. 42:1110-1114.
6. Brown, D. F. J., M. Farrington, and R. E. Warren. 1993. Imipenem-resistant Escherichia coli. Lancet 342:177.
7. Cornaglia, G., L. Guan, R. Fontana, and G. Satta. 1992. Diffusion of meropenem and imipenem through the outer membrane of Escherichia coli K-12 and correlation with their antibacterial activities. Antimicrob. Agents Chemother. 36:1902-1908.
8. BIL-1, a plasmid-mediated class C β-lactamase gene in Escherichia coli BS. Antimicrob. Agents Chemother. 38:1182-1185.
9. Gazouli, M., L. S. Tzouvelekis, E. Prinarakis, V. Miriagou, and E. Tzelepi. 1996. Transferable cefoxitin resistance in enterobacteria from Greek hospitals and characterization of a plasmid-mediated group 1 β-lactamase (LAT-2). Antimicrob. Agents Chemother. 40:1736-1740.
10. Koeck, J. L., G. Arlet, A. Philippon, S. Basmaciogullari, H. V. Thien, Y. Buisson, and J. D. Cavallo. 1997. A plasmid-mediated CMY-2 β-lactamase from an Algerian clinical isolate of Salmonella senftenberg. FEMS Microbiol. Lett. 152:255-260.
11. Lee, E. H., M. H. Nicolas, M. D. Kitzis, G. Pialoux, E. Collatz, and L. Gutmann. 1991. Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem. Antimicrob. Agents Chemother. 35:1093-1098.
12. Lindberg, F., L. Westman, and S. Normark. 1985. Regulatory components in Citrobacter freundii AmpC β-lactamase induction. Proc. Natl. Acad. Sci. USA 82:4620-4624.
13. Lindquisl, S., F. Lindberg, and S. Normark. 1989. Binding of the Citrobacter freundii AmpR regulator to a single DNA site provides both autoregulation and activation of the inducible ampC β-lactamase gene. J. Bacteriol. 171: 3746-3753.
14. Livermore, D. M. 1987. Clinical significance of β-lactamase induction and stable derepression in Gram-negative rods. Eur. J. Clin. Microbiol. 6:439-445.
15. Mainardi, J.-L., P. Mugnier, A. Coutrot, A. Buu-Hoï, E. Collatz, and L. Gutmann. 1997. Carbapenem resistance in a clinical isolate of Citrobacter freundii. Antimicrob. Agents Chemother. 41:2352-2354.
16. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
17. Neuwirth, C., E. Siéblor, J. M. Duez, A. Pechinot, and A. Kazmierczak. 1995. Imipenem resistance in clinical isolates of Proteus mirabilis associated with alterations in penicillin-binding proteins. J. Antimicrob. Chemother. 36:335-342.
18. Nordmann, P., S. Mariotte, T. Naas, R. Labia, and M.-H. Nicolas. 1993. Biochemical properties of a carbapenem-hydrolyzing β-lactamase from Enterobacter cloacae and cloning into Escherichia coli. Antimicrob. Agents Chemother. 37:939-946.
19. Oefner, C., A. Darcy, J. J. Daly, K. Gubernator, R. L. Charnas, I. Heinze, C. Hubschwerfen, and F. K. Winkler. 1990. Refined crystal structure of Citrobacter freundii indicates a mechanism for β-lactam hydrolysis. Nature 343:284-288.
20. Osano, E., Y. Arakawa, R. Wacharotayankun, M. Ohta, T. Horii, H. Ito, F. Yoshimura, and N. Kato. 1994. Molecular characterization of an enterobacterial metallo β-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob. Agents Chemother. 38:71-78.
21. Raimondi, A., A. Traverse, and H. Nikaido. 1991. Imipenem-and meropenem-resistant mutants of Enterobacter cloacae and Proteus rettgeri lack porins. Antimicrob. Agents Chemother. 35:1174-1180.
22. Rasmussen, B. A., K. Bush, D. Keeney, Y. Yang, R. Hare, C. O'Gara, and A. A. Medeiros. 1996. Characterization of IMI-1 β-lactamase, a novel class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae. Antimicrob. Agents Chemother. 40:2080-2086.
23. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
24. Stapleton, P., K. Shannon, and I. Phillips. 1995. DNA sequence differences of ampD mutants of Citrobacter freundii. Antimicrob. Agents Chemother. 39: 2494-2498.
25. Stapleton, P., K. Shannon, and I. Phillips. 1995. The ability of β-lactam antibiotics to select mutants with derepressed β-lactamase synthesis from Citrobacter freundii. J. Antimicrob. Chemother. 36:483-496.
26. Stapleton, P., P.-J. Wu, A. King, K. Shannon, G. French, and I. Phillips. 1995. Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli. Antimicrob. Agents Chemother. 39:2478-2483.
27. LAT-1) found in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 38:2207-2209.
28. Verdet, C., G. Arlet, S. Ben Redjeb, A. Ben Hassen, P. H. Lagrange, and A. Philippon. 1998. Characterization of CMY-4, an AmpC-type plasmid-mediated beta-lactamase in a Tunisian clinical isolate of Proteus mirabilis. FEMS Microbiol. Lett. 169:235-240.
29. Yang, Y., P.-J. Wu, and D. M. Livermore. 1990. Biochemical characterization of a β-lactamase that hydrolyzes penem and carbapenems from two Serratia marcescens isolates. Antimicrob. Agents Chemother. 34:755-758.